A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults
Latest Information Update: 22 Apr 2025
At a glance
- Drugs VRC MARADC087 00 VP (Primary)
- Indications Marburg virus disease
- Focus Adverse reactions
Most Recent Events
- 22 Apr 2025 Status changed from not yet recruiting to recruiting.
- 08 Oct 2024 New trial record